Nautilus Biotechnology, Inc.
2021 Q2 - 2025 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 84 | 0.0% | 42,916 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 107 | 0.0% | 147,497 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 58 | 0.0% | 67,293 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 66 | 0.0% | 39,004 | 12/31/2024 |
| 2023 Q4 | 2/14/2024 | 65 | 0.0% | 21,710 | 12/31/2023 |
| 2023 Q2 | 8/11/2023 | 164 | 0.0% | 42,445 | 6/30/2023 |
| 2023 Q1 | 5/16/2023 | 270 | 0.0% | 97,366 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 43 | 0.0% | 23,818 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 79 | 0.0% | 37,170 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 334 | 0.0% | 124,217 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 779 | 0.0% | 179,595 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 820 | 0.0% | 158,252 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,313 | 0.0% | 213,845 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 268 | 0.0% | 26,536 | 6/30/2021 |